Evaluation of the Cue Health point-of-care COVID-19 (SARS-CoV-2 nucleic acid amplification) test at a community drive through collection
Detection Principle
NucleicAcid-Others
Target
N gene
Testing Method Category
PCR_KIT
Testing Method
Cue COVID-19 test (Cue Health Inc., San Diego, CA)
Testing Method - Additional Info
Comparison of POC kit based on isothermal amplification with RT-PCR Hologic Aptima SARS-CoV-2 (Hologic, Marlborough MA) assay (targeting ORF1ab) and in-house developed Taqman RT-PCR (targeting N gene)
Reported Performance
Positive percentage agreement: 91.7% ; Negative percentage agreement: 98.4% ; remarks: POC compared to Hologic Aptima test
Sample Size
292 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements